BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28694421)

  • 21. Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma.
    Xu J; Hu Z
    Biomed Pharmacother; 2016 Apr; 79():17-22. PubMed ID: 27044807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter methylation regulates cigarette smoke-stimulated cyclooxygenase-2 expression in esophageal squamous cell carcinoma.
    Meng XY; Zhu ST; Zhou QZ; Li P; Wang YJ; Zhang ST
    J Dig Dis; 2012 Apr; 13(4):208-13. PubMed ID: 22435505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.
    Zhao L; Li QQ; Zhang R; Xi M; Liao YJ; Qian D; He LR; Zeng YX; Xie D; Liu MZ
    Tumour Biol; 2012 Aug; 33(4):1115-23. PubMed ID: 22389159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
    Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706].
    Li LW; Yu XY; Li XY; Guo LP; Zhou Y; Lu SX
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):570-3. PubMed ID: 22325214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
    Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
    Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
    Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
    Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
    Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
    Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K; Yang Y; Zhao J; Zhao S
    Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T; Tanaka T; Yukawa K; Umesaki N
    Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
    Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
    Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma.
    Arai M; Imazeki F; Sakai Y; Mikata R; Tada M; Seki N; Shimada H; Ochiai T; Yokosuka O
    Oncol Rep; 2008 Aug; 20(2):405-12. PubMed ID: 18636205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
    Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
    Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.